Facing resistance of H.pylori infection - Wikidata - awgldk - TriplyDB

Facing resistance of H.pylori infection

Facing resistance of H.pylori infection

http://www.wikidata.org/entity/Q33596218

about

The role of adenotonsillar tissues as a reservoir for Helicobacter pylori and Helicobacter hepaticus The role of Helicobacter pylori and CagA in response to treatment in Iranian Gastroesophageal Reflux Diseases patients.Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes

P2860

Q33596298-1E1D5CFB-12BB-46B6-AA82-D6CFAC7C03C8 Q39134562-252C1CE5-A4A3-4042-996E-4EFD77D8DA09 Q41109955-6CA6822B-96B5-46D7-940D-FBEA10AF0CD4

P2860

Facing resistance of H.pylori infection

http://www.wikidata.org/entity/Q33596218

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Facing resistance of H.pylori infection

@ast

Facing resistance of H.pylori infection

@en

type

label

Facing resistance of H.pylori infection

@ast

Facing resistance of H.pylori infection

@en

prefLabel

Facing resistance of H.pylori infection

@ast

Facing resistance of H.pylori infection

@en

P1433

Q33596218-F4AF2B2A-8BCA-420D-9791-E27C654839A7

P1476

Q33596218-C300F406-5F2B-4C24-A363-E276C571FA0E

P2093

Q33596218-9222E5CF-D1BA-4163-9583-B36C9C31FDA6

P2860

Q33596218-02FDC512-DE72-4727-9CAC-A23B133097A0

Q33596218-05246682-B53B-4E63-9560-FC02626F6B86

Q33596218-09584E85-ABB9-4FC5-8224-CE1B8F5DAEA8

Q33596218-0D862F15-DCFA-42A9-8AA3-B8A8B243497D

Q33596218-17CCB4B9-CB80-4D99-AA73-66EEE3F073AB

Q33596218-1C77D8C6-42F1-4DB9-83FE-3A912EE57E38

Q33596218-1D0FFAAC-7D06-4865-A917-771B9C3BBA25

Q33596218-28AA46B1-3A3C-4835-ADDD-C9A344EA7DEE

Q33596218-2EB0552C-A136-44D6-A41E-07140B125C57

Q33596218-3CC51E9B-9698-4CCD-B3CB-97E8C8BF96AC

P304

Q33596218-F8FAA21D-DD31-4325-91FE-A13D5CFDFF08

P31

Q33596218-8D29EDFF-DBFE-49B8-803E-36E79ADC3C65

P433

Q33596218-A4B2D083-AD18-4971-9929-808DC428EE53

P478

Q33596218-B27B94EF-E987-49C6-BCE3-EF4E57E5927C

P577

Q33596218-EA782322-509F-4586-9C2D-03123CAD7977

P698

Q33596218-CF1793C4-E8F0-4D5E-A1CD-550A1F281D72

P921

Q33596218-055010DD-784E-4B99-98F8-4CB0DDB352A4

P932

Q33596218-D45FE4A5-A75C-43E2-AD16-8B73796C1897

P1433

Gastroenterology and hepatology from bed to bench

P1476

Facing resistance of H.pylori infection

@en

P2093

Mohammad Reza Zali

http://www.w3.org/2001/XMLSchema#string

P2860

New concepts of resistance in the treatment of Helicobacter pylori infections

Effect of high-dose aspirin on Helicobacter pylori eradication

Persister cells, dormancy and infectious disease

Why is long-term therapy required to cure tuberculosis?

Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.

American College of Gastroenterology guideline on the management of Helicobacter pylori infection.

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.

Helicobacter pylori is invasive and it may be a facultative intracellular organism.

Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence.

P304

3-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24834148

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

P932

4017401

http://www.w3.org/2001/XMLSchema#string